Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed ...

The global Clinical Analytics Market, valued at US$27.65 billion in 2024, stood at US$33.09 billion in 2025 and is projected to advance ...

Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high treatment response ICT01 has the potential to be a ...

The latest announcement is out from Regeneus Ltd. ( (AU:CMB) ).

Standing between Dymocks’ health aisle and tarot card section, I once comforted myself over heartbreak with the hard-earned ...

Medicare beneficiaries with amyotrophic lateral sclerosis (ALS) were found to have more than 3 times the Medicare expenditures and beneficiary liability of the average Medicare beneficiary.

In a sweeping expansion of its cancer drug portfolio, global biopharmaceutical powerhouse Ipsen SAS announced Wednesday that ...

The AI platform goes through unstructured medical records to surface eligible trials, allowing clinical research teams to ...

Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...

| Clinical development is undergoing a structural shift. Protocols are growing more complex, budgets are shrinking, and ...